← Back to Analyst Consensus 
FATE Buy
FATE THERAPEUTICS INC
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| Aug 14, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 14, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Jun 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 4, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Oct 31, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $5 | 44% |
| Oct 27, 2025 | Wedbush | upgrade | Neutral → Outperform | $7 | 58% |
| Oct 27, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Aug 13, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $2.5 | 54% |
| Jun 12, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| May 14, 2025 | Barclays | maintain | Overweight → Overweight | $2 | 53% |
| May 14, 2025 | Baird | maintain | Neutral → Neutral | $4 | 55% |
| May 14, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Mar 6, 2025 | Stifel | maintain | Hold → Hold | $3 | 53% |
| Mar 6, 2025 | Wedbush | reiterate | Neutral → Neutral | $5 | 58% |
| Mar 6, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Mar 6, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Nov 19, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Nov 13, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Aug 22, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $5 | 44% |
| Aug 14, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Jun 17, 2024 | Piper Sandler | upgrade | Neutral → Overweight | $6 | 54% |
| May 16, 2024 | HC Wainwright & Co. | maintain | Neutral → Neutral | $5 | 44% |
| May 10, 2024 | Canaccord Genuity | maintain | Buy → Buy | $9 | 48% |
| May 10, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $6 | 53% |
| May 10, 2024 | Wedbush | maintain | Neutral → Neutral | $5 | 58% |
| May 10, 2024 | Piper Sandler | maintain | Neutral → Neutral | $4 | 54% |
| May 6, 2024 | Wedbush | reiterate | Neutral → Neutral | $7 | 58% |
| Apr 23, 2024 | Wedbush | reiterate | Neutral → Neutral | $7 | 58% |
| Apr 11, 2024 | Needham | reiterate | — → Hold | $0 | 50% |
| Mar 28, 2024 | B of A Securities | maintain | Underperform → Underperform | $6 | 53% |
| Mar 19, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $7 | 44% |
| Feb 27, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $7 | 54% |
| Feb 27, 2024 | BMO Capital | maintain | Market Perform → Market Perform | $7 | 53% |
| Feb 27, 2024 | Barclays | maintain | Overweight → Overweight | $10 | 53% |
| Feb 27, 2024 | Wedbush | maintain | Neutral → Neutral | $7 | 58% |
| Feb 27, 2024 | Oppenheimer | reiterate | Perform → Perform | $0 | 52% |
| Nov 20, 2023 | Mizuho | maintain | Buy → Buy | $8 | 52% |
| Nov 13, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $3 | 54% |
| Nov 9, 2023 | BMO Capital | maintain | Market Perform → Market Perform | $6 | 53% |
| Nov 9, 2023 | Wedbush | maintain | Neutral → Neutral | $3 | 58% |
| Nov 9, 2023 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Sep 7, 2023 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $5 | 50% |
| Aug 16, 2023 | Truist Securities | reiterate | Hold → Hold | $7 | 54% |
| Aug 10, 2023 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $5 | 54% |
| Aug 10, 2023 | Barclays | maintain | Overweight → Overweight | $6 | 53% |
| Aug 9, 2023 | BMO Capital | maintain | Market Perform → Market Perform | $5.4 | 53% |
| Aug 9, 2023 | EF Hutton | reiterate | Buy → Buy | $10 | 30% |
| May 5, 2023 | HC Wainwright & Co. | reiterate | — → Neutral | $7 | 44% |
| May 4, 2023 | Stifel | maintain | — → Hold | $5 | 53% |
Price Target Trend
Jun 4, 2026 Oct 26, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days